Compare Cassava Sciences Inc (FLNA) vs Hilton Hotels Corporation Common Stock (HLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Hilton Hotels Corporation Common Stock — how do they compare? Cassava Sciences Inc trades at $0.97 (market cap $47.75M), while Hilton Hotels Corporation Common Stock trades at $319 (market cap $70.00B). The key difference: Hilton Hotels Corporation Common Stock is far larger — about 1466× Cassava Sciences Inc's market cap, and Hilton Hotels Corporation Common Stock pays a 0.19% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| FLNA | HLT | |
|---|---|---|
Market Cap | $47.75M | $70.00B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.64 | $350.22 |
52-Week Low | $0.87 | $256.75 |
Enterprise Value | -$34.93M | $83.01B |
Dividend Yield | — | 0.19% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Hilton Hotels Corporation Common Stock
Hilton Worldwide Holdings operates 1,074,791 rooms across its 18 brands addressing the midscale through luxury segments as of Dec. 31, 2021. Hampton and Hilton are the two largest brands by total room count at 28% and 21%, respectively, as of Dec. 31, 2021. Recent brands launched over the last few years include Home2, Curio, Canopy, Tru, and Tempo. Managed and franchised represent the vast majority of adjusted EBITDA, predominantly from the Americas regions.
Read more on HLT →
